BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 16405407)

  • 1. A Greek family with a follicular variant of familial papillary thyroid carcinoma: TCO, MNG1, fPTC/PRN, and NMTC1 excluded as susceptibility loci.
    Tsilchorozidou T; Vafiadou E; Yovos JG; Romeo G; McKay J; Lesueur F; Bonora E
    Thyroid; 2005 Dec; 15(12):1349-54. PubMed ID: 16405407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial non-medullary thyroid carcinoma (FNMTC): analysis of fPTC/PRN, NMTC1, MNG1 and TCO susceptibility loci and identification of somatic BRAF and RAS mutations.
    Cavaco BM; Batista PF; Martins C; Banito A; do Rosário F; Limbert E; Sobrinho LG; Leite V
    Endocr Relat Cancer; 2008 Mar; 15(1):207-15. PubMed ID: 18310288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome.
    Malchoff CD; Sarfarazi M; Tendler B; Forouhar F; Whalen G; Joshi V; Arnold A; Malchoff DM
    J Clin Endocrinol Metab; 2000 May; 85(5):1758-64. PubMed ID: 10843148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping a new familial thyroid epithelial neoplasia susceptibility locus to chromosome 8p23.1-p22 by high-density single-nucleotide polymorphism genome-wide linkage analysis.
    Cavaco BM; Batista PF; Sobrinho LG; Leite V
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4426-30. PubMed ID: 18765515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial papillary thyroid carcinoma is genetically distinct from familial adenomatous polyposis coli.
    Malchoff CD; Sarfarazi M; Tendler B; Forouhar F; Whalen G; Malchoff DM
    Thyroid; 1999 Mar; 9(3):247-52. PubMed ID: 10211600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two families with an autosomal dominant inheritance pattern for papillary carcinoma of the thyroid.
    Burgess JR; Duffield A; Wilkinson SJ; Ware R; Greenaway TM; Percival J; Hoffman L
    J Clin Endocrinol Metab; 1997 Feb; 82(2):345-8. PubMed ID: 9024215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial nonmedullary thyroid cancer: a review of the genetics.
    Khan A; Smellie J; Nutting C; Harrington K; Newbold K
    Thyroid; 2010 Jul; 20(7):795-801. PubMed ID: 20465534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic loss of susceptibility loci and the occurrence of BRAF and RAS mutations in patients with familial non-medullary thyroid cancer.
    Na KY; Kim RM; Song EM; Lee JH; Lee J; Soh EY
    J Surg Oncol; 2012 Jan; 105(1):10-4. PubMed ID: 21826673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2.
    Canzian F; Amati P; Harach HR; Kraimps JL; Lesueur F; Barbier J; Levillain P; Romeo G; Bonneau D
    Am J Hum Genet; 1998 Dec; 63(6):1743-8. PubMed ID: 9837827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial papillary thyroid carcinoma: genetics, criteria for diagnosis, clinical features, and surgical treatment.
    Musholt TJ; Musholt PB; Petrich T; Oetting G; Knapp WH; Klempnauer J
    World J Surg; 2000 Nov; 24(11):1409-17. PubMed ID: 11038215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. At least three genes account for familial papillary thyroid carcinoma: TCO and MNG1 excluded as susceptibility loci from a large Tasmanian family.
    McKay JD; Williamson J; Lesueur F; Stark M; Duffield A; Canzian F; Romeo G; Hoffman L
    Eur J Endocrinol; 1999 Aug; 141(2):122-5. PubMed ID: 10427154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancer.
    McKay JD; Thompson D; Lesueur F; Stankov K; Pastore A; Watfah C; Strolz S; Riccabona G; Moncayo R; Romeo G; Goldgar DE
    J Med Genet; 2004 Jun; 41(6):407-12. PubMed ID: 15173224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21.
    McKay JD; Lesueur F; Jonard L; Pastore A; Williamson J; Hoffman L; Burgess J; Duffield A; Papotti M; Stark M; Sobol H; Maes B; Murat A; Kääriäinen H; Bertholon-Grégoire M; Zini M; Rossing MA; Toubert ME; Bonichon F; Cavarec M; Bernard AM; Boneu A; Leprat F; Haas O; Lasset C; Schlumberger M; Canzian F; Goldgar DE; Romeo G
    Am J Hum Genet; 2001 Aug; 69(2):440-6. PubMed ID: 11438887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population.
    Uchino S; Noguchi S; Kawamoto H; Yamashita H; Watanabe S; Yamashita H; Shuto S
    World J Surg; 2002 Aug; 26(8):897-902. PubMed ID: 11965446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial non-medullary thyroid cancer: unraveling the genetic maze.
    Peiling Yang S; Ngeow J
    Endocr Relat Cancer; 2016 Dec; 23(12):R577-R595. PubMed ID: 27807061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping of a gene predisposing to familial thyroid tumors with cell oxyphilia to chromosome 19 and exclusion of JUN B as a candidate gene.
    Kraimps JL; Canzian F; Jost C; Menet E; Amati P; Levillian P; Harach R; Lesueur F; Barbier J; Romeo G; Bonneau D
    Surgery; 1999 Dec; 126(6):1188-94. PubMed ID: 10598206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of HLA DQ4-DR8 haplotype with papillary thyroid carcinomas.
    Porto T; Coelho I; Boavida J; Pereira C; Nunes JM; Mendonça D; Martins B; Sobrinho LG; Leite V
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):179-83. PubMed ID: 16430717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements.
    Mechler C; Bounacer A; Suarez H; Saint Frison M; Magois C; Aillet G; Gaulier A
    Br J Cancer; 2001 Dec; 85(12):1831-7. PubMed ID: 11747322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.
    Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M
    Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct loci on chromosome 1q21 and 6q22 predispose to familial nonmedullary thyroid cancer: a SNP array-based linkage analysis of 38 families.
    Suh I; Filetti S; Vriens MR; Guerrero MA; Tumino S; Wong M; Shen WT; Kebebew E; Duh QY; Clark OH
    Surgery; 2009 Dec; 146(6):1073-80. PubMed ID: 19958934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.